AzTrials
AzTrials

Elderly Patients in Complex SituationsPROCOPESNCT02348892

Evaluation Program of the Benefit of the Coordination of the Course of the Elderly Patient in Health Establishment - Pilot Study.

An observational study of Elderly Patients in Complex Situations, run by Nantes University Hospital at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The large share of chronic diseases correlated with an aging population calls to develop necessary coordination between the hospital and non-hospital (professional of the city, home ...) to create new complementarities. Read more about this study

Who is it for?
Ages 70 years and older
Conditions the study is for
Elderly Patients in Complex Situations
What is being tested?
Coordinator and Classic plan
How many people
100 participants
Where
1 siteFrance
Study dates
Dec 2014to Feb 2016
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 70 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Study population: The eligible patients for the study will be the patients of 70 and more years old hospitalized in the Nantes UH in the acute care medical department internal medical departement medical urgency, rehabilitation unit, neurology, gastro-enterology of the CHU of Nantes and which are in complex medical and social situation, whoever is their motive for hospitalization.

Who may be able to join

  • Patient of 70 and more years old
  • Patient living on Nantes
  • Hospitalized in Nantes UH
  • Patient whose the hospitalization is not relevant at the time of the request of trajectory case manager
  • Patient whose the situation is complex (without solution at the time of the request)
  • Patient (or legal representative) having given his assent of participation

Who cannot join

  • Patient (or legal representative) refusing to participate in the protocol
  • Patient whose follow-up is impossible (ex: programmed move, life expectation)

Trial locations and contacts

1 site in 1 country.

France1 site, 1 recruiting
  • Nantes UH

    Nantes, 44093

    Gilles Berrut, gilles.berrut@chu-nantes.fr

    Dibon Christelle, christelle.dibon@chu-nantes.fr

    Recruiting

Other trials in France

About this study

The large share of chronic diseases correlated with an aging population calls to develop necessary coordination between the hospital and non-hospital (professional of the city, home ...) to create new complementarities.

Since July 2013, the Nantes University Hospital experiences the establishment of a coordinator route patient in Gerontology. The evaluation program of the benefit of coordinating the course in elderly patients in health establishment (PROCOPES) must allow to prove the efficiency of the intervention of a coordinator route patient, following elderly patients in complex situations, both within the hospital and outside the hospital (home, nursing home,...). The objective of PROCOPES is to show the added value of an innovative position that can make the link between the hospital and the city on deemed complex situations.The pilot study results present a strong interest for health care settings, nursing home and in the world of research. It will also permit to have preliminary data for bigest studies.

Being tested
Coordinator, Classic plan

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CoordinatorOther

    Patients in complex situation taken care by coordinator

  • Classic planOther

    Patients in complex situation taken care by classic plan

Study groups in NCT02348892
Study groupRoleWhat they receive
With coordinatorElderly patients, in complex situation, taken care by coordinator
Receives: Other: Coordinator
Without coordinatorElderly patients, in complex situation, taken care by the classic plan
Receives: Other: Classic plan

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cost-utility analysis (CUA)

    A differential cost-utility ratio will be used to compare both interventions. The evaluation of costs will take into account direct health care insurance cost, hospital costs and patient cost (according to the french health care insurance system). The evaluation of utility will be based on the evaluation of patient's quality of life, measured by EuroQol EQ-5D.

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jan 2015 (estimated)
  2. Study startDec 2014
  3. Primary completionFeb 2016 (estimated)
  4. Study completionFeb 2016 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Time perspective
Prospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02348892
Sponsor's protocol ID
RC14_0343
Acronym
PROCOPES
Status last verified
Jan 2015
First submitted
16 Jan 2015
Last updated
28 Jan 2015
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Elderly Patients in Complex Situations, run by Nantes University Hospital at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 28 Jan 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cost-utility analysis (CUA) (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jan 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in